Washington Trust Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History
Washington Trust Advisors, Inc.
- $1.06 Billion
- Q1 2024
A detailed history of Washington Trust Advisors, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 159 shares of BMRN stock, worth $12,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
159
Previous 159
-0.0%
Holding current value
$12,950
Previous $15,000
13.33%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BMRN
# of Institutions
623Shares Held
181MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.52 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.48 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.18 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.14 Billion0.75% of portfolio
-
State Street Corp Boston, MA6.9MShares$562 Million0.03% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...